DermTech, Inc.
DMTKQOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$3496
P/E Ratio—
52W High$0.059
52W Low$0.00001
DermTech, Inc. (DMTKQ) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · DMTKQ · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $15.30M | $14.52M | $11.84M | $5.88M | $3.36M |
| Cost of Revenue | $15.02M | $13.87M | $10.56M | $5.98M | $3.30M |
| Gross Profit | $0.28M | $0.65M | $1.27M | ($0.10M) | $0.06M |
| Gross Margin %(computed) | 1.80% | 4.46% | 10.76% | -1.63% | 1.78% |
| Operating Expenses | |||||
| R&D Expenses | $15.24M | $24.05M | $16.26M | $5.29M | $2.50M |
| G&A Expenses | $43.78M | $36.09M | $24.84M | $13.82M | $0.00M |
| Total Operating Expenses | $104.02M | $118.81M | $78.67M | $35.19M | $17.66M |
| Operating Income | ($103.74M) | ($118.17M) | ($77.40M) | ($35.29M) | ($17.61M) |
| Operating Margin %(computed) | -678.21% | -813.92% | -653.81% | -599.64% | -523.34% |
| Interest Income | $2.85M | $1.34M | $0.15M | $0.04M | $0.00M |
| Interest Expense | $0.01M | $0.00M | $0.00M | $0.00M | $2.66M |
| Income Before Tax | ($100.89M) | ($116.68M) | ($78.33M) | ($36.48M) | ($20.13M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($100.89M) | ($116.68M) | ($78.33M) | ($36.48M) | ($20.13M) |
| Net Margin %(computed) | -659.57% | -803.71% | -661.72% | -619.83% | -598.39% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.09 | $-3.88 | $-2.71 | $-2.15 | $-2.81 |
| Wtd Avg Shares | 32.64M | 30.04M | 28.89M | 16.98M | 7.00M |
| EBITDA | ($97.89M) | ($113.70M) | ($75.10M) | ($34.80M) | ($17.38M) |
| EBITDA Margin %(computed) | -639.99% | -783.20% | -634.41% | -591.38% | -516.77% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · M
Explore more DermTech, Inc. data
About DermTech, Inc. (DMTKQ) Income Statement
DermTech, Inc. (DMTKQ) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, DMTKQ reported revenue of $0.02B, gross profit of $0.00B (gross margin 1.80%), and net income of ($0.10B) — a net profit margin of -659.57%.
Frequently asked questions
DMTKQ · 4 questionsDermTech, Inc. (DMTKQ) reported revenue of $0.02B for 2023, up 5.4% year-over-year.
DMTKQ revenueDMTKQ salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09